Amoxicillin–Clavulanate-Induced Liver Injury - deLemos, Andrew S.; Ghabril, Marwan; Rockey, Don C.; Gu, Jiezhun; Barnhart, Huiman X.; Fontana, Robert J.; Kleiner, David E.; Bonkovsky, Herbert L. (Digestive diseases and sciences, 2016)
Keywords: Age Factors; Alanine Transaminase - blood; Alkaline Phosphatase - blood; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination - adverse effects; Anti-Bacterial Agents - adverse effects; Anti-infective agents; beta-Lactamase Inhibitors - adverse effects; Bilirubin - blood; Biochemistry; Black or African American; Chemical and Drug Induced Liver Injury - blood; Chemical and Drug Induced Liver Injury - epidemiology; Chemical and Drug Induced Liver Injury - etiology; Chemical and Drug Induced Liver Injury - pathology; Cholestasis - blood; Cholestasis - chemically induced; Cholestasis - epidemiology; Cholestasis - pathology; Clavulanate; Cohort Studies; Ethnicity - statistics & numerical data; Female; Gastroenterology; Hepatology; Hispanic or Latino; Humans; Jaundice; Jaundice, Obstructive - blood; Jaundice, Obstructive - chemically induced; Jaundice, Obstructive - epidemiology; Jaundice, Obstructive - pathology; Liver; Liver - pathology; Male; Medical colleges; Medicine; Medicine & Public Health; Middle Aged; Oncology; Original Article; Pneumoviridae; Prospective Studies; Registries; Sex Distribution; Time Factors; Transplant Surgery; Transplantation of organs, tissues, etc; United States - epidemiology; White People; United States; Augmentin; Allergy; Drug-induced liver injury; Clavulanic acid; Liver toxicity; Amoxicillin